Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Natural Phytochemicals: Potential anti-HCV targets in silico approach

ARVIND KUMAR SHAKYA.




Abstract
Cited by 4 Articles

Objective: To identify phytochemicals as NS5B inhibitors against NS5B polymerase in in silico model. The NS5B polymerase is a hepatitis C virus protein involved in the Hepatitis C virus replication. Hepatitis C virus (HCV) is a major causative agent of hepatitis and liver dysfunction.
Material and Methods: Molecular docking method is used to identify binding efficiency between the NS5B (PDB ID: 3UPI) and the virtually designed ligands (phytochemicals) i.e. Gallic acid, Catechin, Resveratrol, Apigenin and Silibinin using Autodock tool 4.2. Molinspiration tool is also used to determine the drug likeness properties of ligands. The docking result was compared to the reference ligand, Dasabuvir.
Results: The molecular docking study revealed that all phytochemicals were formed complex with the HCV NS5B polymerase via hydrogen bond interaction. The phytochemicals showed good binding efficacy with docking score: gallic acid (-5.47 kcal/mol), catechin (-7.31 kcal/mol), resveratrol (-8.14 kcal/mol), apigenin (-8.75 kcal/mol) and silibinin (-10.75 kcal/mol) compared to the Dasabuvir (-11.43 kcal/mol).
Conclusion: The docking results indicated that good docking scores were achieved with druglikeness characteristics of phytochemicals against hepatitis C virus NS5B polymerase which might be due to their interactions with the binding pocket of NS5B.

Key words: HCV NS5B polymerase, Phytochemicals, Molecular Docking, Inhibitors and Binding energy

Key words: HCV NS5B polymerase, 3UPI, Phytochemicals, Molecular Docking, Inhibitors and Binding energy






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.